Eric Stone

Eric Stone is currently an advisor at Kinnos. Eric has previously held positions at Partum Health, Cellevolve, BD, Palvella Therapeutics, 3NT Medical, and MolecularHealth.

Stone began their career in the biotech industry at MolecularHealth, where they served as Vice President of Sales and Marketing. In this role, they were responsible for leading sales and marketing for the company's U.S. operations, rebranding the company, establishing a U.S. commercial operation, and initiating and overseeing a 5-year relationship with the U.S. Food and Drug Administration (FDA).

After leaving MolecularHealth, Stone served as Director of the Board of Directors at Vigilant Biosciences, Inc. from August 2011 to December 2018. In this role, they were responsible for overseeing the company's operations and ensuring compliance with all applicable laws and regulations.

Stone has been an advisor at Kinnos since April 2021. In this role, they provide guidance and advice to the company on its novel endoscopy technology.

Eric Stone received an MBA in Health Care Management from The Wharton School, an Ed.M. in Human Development & Leadership from Harvard University, and a BA in English/Psychology from the University of Pennsylvania.